Revati Shreeniwas

Revati Shreeniwas

Chief Tech/Sci/R&D Officer at ASPEN NEUROSCIENCE, INC.
65 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Revati Shreeniwas, MD, is a Chief Medical Officer at Aspen Neuroscience, Inc., a President at Revati, Inc. and a Member at Continuing Medical Education, Inc. Dr. Shreeniwas was previously employed as a Chief Medical Officer by Bright Minds Biosciences, Inc., a Vice President-Clinical Development by Soleno Therapeutics, Inc., a Chief Medical Officer by NeurAxon Pharma, Inc., a Vice President-Clinical Research & Development by Alvine Pharmaceuticals, Inc., a Principal by CV Therapeutics, Inc., a Principal by Scios, Inc., a Professor by Stanford University, and a Principal by The Trustees of Columbia University in The City of New York.

Revati Shreeniwas active positions

CompaniesPositionStart
ASPEN NEUROSCIENCE, INC. Chief Tech/Sci/R&D Officer 01/12/2025
Corporate Officer/Principal -
Revati, Inc.
President 01/01/2004

Former positions of Revati Shreeniwas

CompaniesPositionEnd
BRIGHT MINDS BIOSCIENCES INC. Chief Tech/Sci/R&D Officer 01/12/2022
SOLENO THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/06/2020
Chief Tech/Sci/R&D Officer 01/01/2017
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Revati Shreeniwas's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

22

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Revati, Inc.

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Revati Shreeniwas